Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Greg Cavers currently holds 3,000 shares of Helus Pharma Inc. (HELP), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Greg Cavers has been a net buyer of HELP stock. They have purchased $38.7K and sold $0 worth of shares.
Greg Cavers's most recent insider trade was on Sep 29, 2026, when they purchased 3,000 shares at $12.91 per share.
Greg Cavers serves as Chief Financial Officer at Helus Pharma Inc. (HELP). They have executed 1 insider transactions totaling $38.7K over their tenure at the company.
Greg Cavers holds the position of Chief Financial Officer at Helus Pharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Greg Cavers has shown a buying trading pattern, with $38.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Greg Cavers was on Sep 29, 2026, when they purchased $38.7K worth of HELP shares. This transaction involved 3,000 shares at $12.91 per share.
Greg Cavers currently owns 3,000 shares of Helus Pharma Inc. (HELP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Greg Cavers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Greg Cavers has 1 Form 4 filings on record as an insider at Helus Pharma Inc..
Set alerts for Greg Cavers and 40,000+ other insiders.